Taking PMVK as an example, it is a target of miR-874, which hindered the mevalonate pathway by depleting geranylgeranyl pyrophosphate (GGPP), subsequently activating the P53 pathway and promoting breast cancer cell apoptosis [24]. The gene discussed is TP53; the disease is breast carcinoma.